El negocio bursátil de PUMA BIOTECHNOLOGY – Observatorio de biopolitica
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
Former Puma Biotech Executive Gets U.S. Prison Term for Insider Trading
Puma – PHARMA
Exhibitor Puma Biotechnology 11-6 - Scripps CME Connection
Puma – PHARMA
Resumen: Puma Biotechnology y Pierre Fabre firman acuerdo de licencia exclusiva para desarrollar y comercializar NERLYNX® (neratinib) en Europa | Business Wire
Puma Biotechnology
Resumen: Puma Biotechnology y Pierre Fabre modifican el acuerdo de licencia de NERLYNX® para incluir la Gran China | Business Wire
PumaBiotech (@pumabiotech) / Twitter
Puma – PHARMA
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Puma Wins 5-Year Extension of Patent on Main Breast Cancer Treatment Drug Nerlynx - Los Angeles Business Journal
Puma Biotechnology: A Speculative Investment At A Discount (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology
Puma Men – PHARMA
La EMA recomienda no aprobar el fármaco de Puma Biotech
Puma – PHARMA
Buy Hering Pharma Muira Puma Mother Tincture Q 30ml | ShopHealthy.in
Compra Acciones de Puma Biotechnology Inc y Comprueba ($PBYI) su Precio de Mercado en eToro.
Puma Biotechnology
Resumen: Puma Biotechnology y Pierre Fabre modifican el acuerdo de licencia de NERLYNX® para incluir la Gran China | Business Wire
PharmaBg
